Schnieders Capital Management LLC Pfizer Inc Transaction History

Schnieders Capital Management LLC

$499 Million
Q4 2024

A detailed history of Schnieders Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Schnieders Capital Management LLC holds 22,896 shares of PFE stock, worth $591,403. This represents 0.12% of its overall portfolio holdings.

Number of Shares

22,896

Previous 24,770 7.57%

Holding current value

$591,403

Previous $716,000 15.22%

% of portfolio

0.12%

Previous 0.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$24.8 - $30.19 $46,475 - $56,576	-1,874 Reduced 7.57%	22,896 $607,000
Q3 2024 Nov 08, 2024	BUY	$27.7 - $31.39 $4,182 - $4,739	151 Added 0.61%	24,770 $716,000
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $288,317 - $337,854	-11,414 Reduced 31.68%	24,619 $688,000
Q1 2024 Apr 25, 2024	SELL	$25.89 - $29.73 $361,424 - $415,030	-13,960 Reduced 27.92%	36,033 $999,000
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $461,769 - $599,787	-17,672 Reduced 26.12%	49,993 $1.44 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $15,948 - $18,642	-497 Reduced 0.73%	67,665 $2.24 Million
Q2 2023 Aug 01, 2023	BUY	$36.12 - $41.79 $79,030 - $91,436	2,188 Added 3.32%	68,162 $2.5 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $44,313 - $57,690	1,125 Added 1.73%	65,974 $2.69 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $372,535 - $486,303	8,923 Added 15.96%	64,849 $3.32 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $345,704 - $422,018	7,900 Added 16.45%	55,926 $2.45 Million
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $4,653 - $5,517	-100 Reduced 0.21%	48,026 $2.52 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $109,983 - $136,282	2,404 Added 5.26%	48,126 $2.49 Million
Q4 2021 Feb 03, 2022	SELL	$41.32 - $61.25 $991 - $1,470	-24 Reduced 0.05%	45,722 $2.7 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $10,793 - $13,865	-275 Reduced 0.6%	45,746 $1.97 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $34,114 - $38,646	-950 Reduced 2.02%	46,021 $1.8 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $26,524 - $29,913	-792 Reduced 1.66%	46,971 $1.7 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $64,898 - $82,523	1,939 Added 4.23%	47,763 $1.76 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $539 - $633	17 Added 0.04%	45,824 $1.68 Million
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $81,414 - $98,767	2,703 Added 6.27%	45,807 $1.5 Million
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $88,550 - $126,519	-3,276 Reduced 7.06%	43,104 $1.41 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $235,838 - $267,647	-7,164 Reduced 13.38%	46,380 $1.82 Million
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $512,627 - $664,727	-15,778 Reduced 22.76%	53,544 $1.92 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $115,525 - $129,708	-3,124 Reduced 4.31%	69,322 $3 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $275,437 - $302,614	-7,345 Reduced 9.21%	72,446 $3.08 Million
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $100,022 - $114,036	-2,600 Reduced 3.16%	79,791 $3.48 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $19,199 - $23,288	-557 Reduced 0.67%	82,391 $3.63 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $18,139 - $19,337	550 Added 0.67%	82,948 $3.01 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $452,005 - $524,388	14,165 Added 20.76%	82,398 $2.92 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $256,101 - $271,733	7,700 Added 12.72%	68,233 $2.47 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.88 Million - $2.07 Million	60,533	60,533 $2.16 Million

Others Institutions Holding PFE

# of Institutions

3,241

Shares Held

3.66B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schnieders Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schnieders Capital Management LLC with notifications on news.

Account

Schnieders Capital Management LLC Pfizer Inc Transaction History